Abstract
Nodules with GGO components have been known as indolent tumors with a low risk of node metastasis, while occult lymph node metastasis (OLNM) is observed in 15-20% even in clinical stage I non-small cell lung cancer (NSCLC) with radiologically solid nodules. We aimed to evaluate predictive factors for occult lymph node metastasis (OLNM) in clinical stage IA NSCLC patients using a prospective observational cohort (OREX-1A: Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer (NCT03066297)).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
